Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
Authors
Keywords
-
Journal
eLife
Volume 6, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2017-01-17
DOI
10.7554/elife.19671
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
- (2016) F. Pietrantonio et al. Cancer Discovery
- Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
- (2016) Stefan Grossauer et al. Oncotarget
- Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification
- (2015) Midea Gierke et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- BRAFMutation andCDKN2ADeletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
- (2015) Matthew Mistry et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates
- (2015) Daniel F. Egan et al. MOLECULAR CELL
- Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy
- (2015) Christina H. Eng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
- (2015) L. G. Ahronian et al. Cancer Discovery
- EGFR blockade prevents glioma escape from BRAFV600E targeted therapy
- (2015) Tsun-Wen Yao et al. Oncotarget
- Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
- (2015) Catherine Louise Penman et al. Frontiers in Oncology
- Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib
- (2014) Megan L Goodall et al. Autophagy
- BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
- (2014) H. Rizos et al. CLINICAL CANCER RESEARCH
- Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
- (2014) Xiao-Hong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy
- (2014) Baptiste Ronan et al. Nature Chemical Biology
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pilomyxoid astrocytoma treated successfully with vemurafenib
- (2014) Mary Skrypek et al. PEDIATRIC BLOOD & CANCER
- Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
- (2014) J. M. M. Levy et al. Cancer Discovery
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to RAF Inhibitors Revisited
- (2013) Edward Hartsough et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vemurafenib in pediatric patients withBRAFV600Emutated high-grade gliomas
- (2013) Francisco Bautista et al. PEDIATRIC BLOOD & CANCER
- Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
- (2013) Luis L Rojas-Puentes et al. Radiation Oncology
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy
- (2012) Paola Maycotte et al. Autophagy
- Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With MetastaticBRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor
- (2012) Kevin B. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful rechallenge in two patients with BRAF-V600-mutant melanoma who experienced previous progression during treatment with a selective BRAF inhibitor
- (2012) Amélie Clémentine Seghers et al. MELANOMA RESEARCH
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
- (2012) Maria R. Girotti et al. Cancer Discovery
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
- (2011) K. H. T. Paraiso et al. CANCER RESEARCH
- Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
- (2011) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Modulation of pediatric brain tumor autophagy and chemosensitivity
- (2011) Jean M. Mulcahy Levy et al. JOURNAL OF NEURO-ONCOLOGY
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma
- (2010) Q.-W. Fan et al. Science Signaling
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now